Skip to main content
Victor Prieto, MD, Pathology, Houston, TX

VictorG.PrietoMDPhD

Pathology Houston, TX

Dermatopathology, Anatomic Pathology, Surgical Pathology

Full Professor

Dr. Prieto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Prieto's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Dermatopathology, 1995 - 1996
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1991 - 1994
  • Universidad Central de Barcelona
    Universidad Central de BarcelonaPhD, Cellular Biology, PhD cum laude, 1989 - 1991
  • Other
    OtherClass of 1986, MD

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2001 - 2026
  • NC State Medical License
    NC State Medical License 1996 - 2006
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Dermatopathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Melanoma Coexisting with Solar Elastosis: A Potential Pitfall in the Differential Diagnosis Between Nevus and Melanoma  
    Michael T Tetzlaff, Victor G Prieto, Phyu P Aung, Priyadharsini Nagarajan, ScienceDirect
  • Join now to see all

Press Mentions

  • Major Pathologic Response to Neoadjuvant Pembrolizumab in Advanced Melanoma Trial Exceeds 50%
    Major Pathologic Response to Neoadjuvant Pembrolizumab in Advanced Melanoma Trial Exceeds 50%October 25th, 2023
  • Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%
    Pembrolizumab Trial in Advanced Melanoma Shows Major Pathological Response Exceeding 50%October 25th, 2023